← Back to Patent Explorer
US3862885A Expired / Lapsed US ⏱️ 0.0 years remaining

Determination of uric acid in blood with uricase

Assignee: Ono Pharmaceutical Co Ltd
•
Filing: 1971-11-19
•
Granted: 1975-01-28
•
Expires: 1991-11-19
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A process for quantitively determining uric acid in blood with uricase characterized by making microbe-originated uricase act on uric acid in blood in the presence of a catalase inhibitor and a buffer effective to maintain the pH at 5.5 to 7.0 and measuring the quantity of the generated hydrogen peroxide under a condition of a pH of 4.0 to 7.0 in the presence of an anionic surface active agent, a chromogen developing a color with hydrogen peroxide and a substance having a function of separating free oxygen from hydrogen peroxide and catalysing the oxidation of the chromogen.

Inventors

  • 👤 Kunio Kano
  • 👤 Naohiro Kayama
  • 👤 Hiroshi Terashima
  • 👤 Yoshitaka Nakagiri

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 16:46
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/62

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 22 words
The process as recited in claim 1 wherein a buffer which maintains a pH range of 5.7-6.5 is added to the blood.
Claim 2
Dependent Claim 21 words
The process as recited in claim 2 wherein the buffer is a phosphate buffer, a citrate buffer or an acetate buffer.
Claim 3
Dependent Claim 26 words
The process as recited in claim 1 wherein the hydrogen peroxide is measured by contacting the hydrogen peroxide with a chromogen whereby a color is produced.
Claim 4
Dependent Claim 18 words
The process as recited in claim 4 wherein the chromogen is o-tolidine, 2,7-diaminofluorene, dimethyl-p-phenylenediamine, diethyl-p-phenylenediamine, o-dianididine, or o-aminophenol.
Claim 5
Dependent Claim 25 words
The process as recited in claim 4 wherein the hydrogen peroxide is contacted with the chromogen in a buffer solution having a pH of 4-7.
Claim 6
Dependent Claim 14 words
The process as recited in claim 6 wherein the pH is 4 - 4.5.
Claim 7
Dependent Claim 16 words
The process as recited in claim 1 wherein a catalase inhibitor is added to the blood.
Claim 8
Dependent Claim 19 words
The process as recited in claim 8 wherein the catalase inhibitor is sodium azide, potassium cyanide, or sodium cyanide.
Claim 9
Dependent Claim 16 words
The process as recited in claim 4 wherein a dispersing agent is added to the chromogen.
Claim 10
Dependent Claim 19 words
The process as recited in claim 10 wherein the dispersing agent is polyethylene glycol, polyvinyl alcohol, or polyvinyl pyrrolidone.
Claim 11
Dependent Claim 15 words
The process as recited in claim 1 wherein copper ions are added to the blood.
Claim 12
Dependent Claim 24 words
The process as recited in claim 4 wherein the hydrogen peroxide is contacted with the chromogen in the presence of a chromogen oxidation catalyst.
Claim 13
Dependent Claim 12 words
The process as recited in claim 13 wherein the catalyst is peroxidase.

References Cited (Backward Citations)

US3335069A Cited
US3367842A Cited
US3475276A Cited
US3677903A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1978-01-27 1978-07-29 1979-01-28 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1982-01-27 1982-07-29 1983-01-28 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1986-01-27 1986-07-29 1987-01-28 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag